Neuroleptic dysphoria: revisiting the concept 50 years later

Authors


A. George Awad, 2175 Keele Street, Suite #243A, Toronto, ON, Canada M6M 3Z4.
E-mail: gawad@hrrh.on.ca

Abstract

Objective:  To review the concept of neuroleptic dysphoria, its historical development and the current state of the art.

Method:  This paper is based on extensive but selective literature review and also draws on our extensive clinical and research experiences.

Results:  Although the construct of neuroleptic dysphoria was recognized shortly following the introduction of the first antipsychotic, chlorpromazine, it took several years for the concept to receive adequate research and clinical attention. Without having direct evidence to link neuroleptic dysphoria to dopamine, it was generally understood that dopamine played a significant role in its genesis. In recent neuroimaging studies and dopamine depletion strategies, the role of dopamine in the genesis of neuroleptic dysphoria has been directly confirmed.

Conclusion:  Neuroleptic dysphoria is a valid construct, which has significant implications for treatment and outcome. It is now clear that it relates to dopamine activities in the nigrostriatal complex. Recent research has also raised the issue of whether neuroleptic dysphoria is a variant of extrapyramidal symptoms. Meanwhile, the role of dopamine in both the genesis of neuroleptic dysphoria and addictive behaviour has raised the issue of both conditions being different facets of the schizophrenic disease process. The recent interface of addiction and psychiatry research may have opened a new science: the science of subjective tolerability disorders.

Ancillary